Career history of Craig Bottomley
Former positions of Craig Bottomley
| Companies | Position | Start | End |
|---|---|---|---|
| STAR COMBO PHARMA LIMITED | Director/Board Member | 2019-04-16 | 2019-08-15 |
| BWX | Director/Board Member | 2013-04-25 | 2017-03-01 |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Director/Board Member | 2005-11-27 | 2010-11-21 |
| Chief Operating Officer | 2009-10-25 | 2010-11-21 | |
| Founder | 2005-11-27 | 2010-11-21 | |
| MAYNE PHARMA GROUP LIMITED | Director/Board Member | 2005-11-27 | 2010-07-28 |
| Chief Operating Officer | 2005-11-27 | 2010-07-28 | |
| GUD HOLDINGS LIMITED | Chief Executive Officer | - | - |
| Pacific Dunlop Cables Group | Chief Executive Officer | - | - |
| MIRRABOOKA INVESTMENTS LIMITED | Director/Board Member | - | - |
Statistics
International
| Australia | 8 |
Operational
| Director/Board Member | 5 |
| Chief Operating Officer | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| BWX | Consumer Non-Durables |
| GUD HOLDINGS LIMITED | Consumer Durables |
| STAR COMBO PHARMA LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Health Technology |
Mirrabooka Investments Ltd.
 Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
| Pacific Dunlop Cables Group |
- Stock Market
- Insiders
- Craig Bottomley
- Experience
